SREBF1 and neoplasm: Knockout of SREBP1 in HCC cells induced growth arrest and apoptosis, as well as inhibited the migration and invasion of tumor cells, whereas the overexpression of SREBP1 promoted cellular proliferation, suggesting that SREBP1 may be a therapeutic target for HCC [6,7].